Cita APA

Cases, A., Puchades, M., Casas-Todoli, J., Nuñez, J., Peña, C., & Gorriz, J. (2026). Effect of IV ferric carboxymaltose treatment on platelet counts and serum transferrin levels in CKD patients not on dialysis with iron deficiency: Potential implications for thrombogenicity.

Citación estilo Chicago

Cases, A., MJ Puchades, J. Casas-Todoli, J. Nuñez, CJ Peña, y JL Gorriz. Effect of IV Ferric Carboxymaltose Treatment On Platelet Counts and Serum Transferrin Levels in CKD Patients Not On Dialysis With Iron Deficiency: Potential Implications for Thrombogenicity. 2026.

Cita MLA

Cases, A., et al. Effect of IV Ferric Carboxymaltose Treatment On Platelet Counts and Serum Transferrin Levels in CKD Patients Not On Dialysis With Iron Deficiency: Potential Implications for Thrombogenicity. 2026.